Aditya P. Mohanty - 15 Mar 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Chief Executive Officer, Director
Signature
/s/ Will Pridgen, Attorney-in-Fact for Aditya P. Mohanty
Issuer symbol
BIORQ
Transactions as of
15 Mar 2023
Net transactions value
-$56,965
Form type
4
Filing time
17 Mar 2023, 21:18:57 UTC
Previous filing
05 Jan 2023
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Award $0 +155,550 +139% $0.000000 267,545 15 Mar 2023 Direct F1
transaction BIOR Common Stock Award $0 +44,879 +17% $0.000000 312,424 15 Mar 2023 Direct F2
transaction BIOR Common Stock Tax liability $56,965 -22,252 -7.1% $2.56 290,172 15 Mar 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 155,550 restricted stock units ("RSUs"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer.
F2 Consists of 44,879 RSUs, which vested upon grant.
F3 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.